Omar Burschtin, MD
Sleep Medicine · New York, NYNPI 1821082058
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $64,938 of the $70,673 with a category attached, or 91.9%. Itamar Medical Inc accounts for 97.3% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $62,430 and has fallen 99.9% since, to $63 in 2025. Among sleep medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 16 payments — averaging $4417.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Itamar Medical Inc$69K
- Inspire Medical Systems, Inc.$1K
- ZOLL Respicardia, Inc.$140
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$111
- Jazz Pharmaceuticals Inc.$81
- GSK$43
- plus $98 from 3 others
What the payments were for
- Consulting fees$64,93892%
- Travel & lodging$6411%
- Food & beverage$5,0947%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Itamar Medical Inc | 6 | $68,770 |
| Inspire Medical Systems, Inc. | 2 | $1,429 |
| ZOLL Respicardia, Inc. | 1 | $140 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $111 |
| Jazz Pharmaceuticals Inc. | 1 | $81 |
| GSK | 2 | $43 |
| Harmony Biosciences LLC | 1 | $42 |
| ZOLL Medical Corporation | 1 | $37 |
| Lilly USA, LLC | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WatchPat$64,888
- WatchPATONE$3,822
- Inspire Upper Airway Stimulation System$1,429
- remede System$140
- TRULANCE$111
How this compares
$70,673 in reported general payments places this provider in the 95th percentile of 81 sleep medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 31 | $341 |
| Clonazepam | 28 | $204 |
| Ropinirole Hcl | 11 | $111 |
| Modafinil | 12 | $108 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in New York
- David RapoportNew York$313K
- Ofer JacobowitzNew York$141K
- Andrew WestwoodNew York$82K
- Maha AhmadNew York$38K
- Daniel BaroneNew York$37K
- Vincent GrbachNew York$21K
- Andrew VargaNew York$19K
- Courtney ChouNew York$16K
- Klaus Dieter LessnauNew York$14K
- Oren CohenNew York$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.